Sun Pharma Advanced Research Company
SPARC · Pharma > Pharmaceuticals & Drugs Listing date: July 18, 2007 · Employees: 410 · Mumbai · http://www.sparc.life

Stock Price vs Company Growth
1d
5.0%
1w
12.6%
1m
42.6%
3m
38.1%
6m
5.9%
1y
14.3%
5y
6.0%
10y
2.9%
all
6.0%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 226 5.0%
221
474
Company Overview

Sales
107 Cr
Growth: 9.9%
Profit after Tax
-363 Cr
Growth: 43.3%
Small Cap
7,321 Cr
P/S: 68.6x
Industry P/S: 2.6x
Fundamentals

Sales (Cr) ₹ 107
Growth 9.9%
EBITDA -361.7%
P/S 68.6x
Dividend 0.0%
P/E -20.1x
Book Value ₹ 1
PEG Ratio -2.0x
ROE -146.1%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Shanghvi Finance Private Limited
52.36 %
Dilip Shantilal Shanghvi
10.72 %
Aditya Medisales Limited
1.87 %
Raksha S.Valia
1.58 %
Sudhir Valia
0.7 %
Others
Sun Pharmaceutical Industries Key Employees Benefit Trust
3.94 %
Lakshdeep Investments & Finance (P) Ltd.
1.94 %
Increase    Decrease    No change
Company Profile Detailed

The company is engaged in the pharmaceutical research and development. The company’s core focus is innovation and new product development for global markets. SPARC undertakes projects in research and technology for new chemical entities (NCE’s) or new molecules, and novel drug delivery systems (NDDS).
Investors (66)
Followers (5)